Genetic Testing Requires NGS and Sanger Methodologies
Overview
Overview
Authors
Authors
Affiliations
Affiliations
Soon will be listed here.
Abstract
Investigators from the EuroEPINOMICS rare epilepsy syndromes Dravet working group performed whole-exome sequencing on 31 trios that had been reported negative for SCN1A mutations by Sanger sequencing.
Citing Articles
Deng Q, Li W, Huang Y, Wang H, Zhou X, Guan Z Front Oncol. 2025; 14:1531972.
PMID: 39927117 PMC: 11803635. DOI: 10.3389/fonc.2024.1531972.
Rocca M, Msaki A, Ghezzi M, Cosci I, Pilichou K, Celeghin R J Assist Reprod Genet. 2020; 37(4):753-762.
PMID: 32242295 PMC: 7183017. DOI: 10.1007/s10815-020-01747-0.
References
1.
Jennings L, Yu M, Zhou L, Rand C, Berry-Kravis E, Weese-Mayer D
. Comparison of PHOX2B testing methods in the diagnosis of congenital central hypoventilation syndrome and mosaic carriers. Diagn Mol Pathol. 2010; 19(4):224-31.
DOI: 10.1097/PDM.0b013e3181eb92ff.
View
2.
Schrijver I, Aziz N, Farkas D, Furtado M, Gonzalez A, Greiner T
. Opportunities and challenges associated with clinical diagnostic genome sequencing: a report of the Association for Molecular Pathology. J Mol Diagn. 2012; 14(6):525-40.
PMC: 6504171.
DOI: 10.1016/j.jmoldx.2012.04.006.
View
3.
Djemie T, Weckhuysen S, von Spiczak S, Carvill G, Jaehn J, Anttonen A
. Pitfalls in genetic testing: the story of missed SCN1A mutations. Mol Genet Genomic Med. 2016; 4(4):457-64.
PMC: 4947864.
DOI: 10.1002/mgg3.217.
View